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Human immunodeficiency virus (HIV) relies heavily on the host cellular machinery for
production of viral progeny. To exploit cellular proteins for replication and to overcome
host factors with antiviral activity, HIV has evolved a set of regulatory and accessory
proteins to shape an optimized environment for its replication and to facilitate evasion
from the immune system. Several cellular pathways are hijacked by the virus to modulate
critical steps during the viral life cycle. Thereby, post-translational modifications (PTMs)
of viral and cellular proteins gain increasingly attention as modifying enzymes regulate
virtually every step of the viral replication cycle. This review summarizes the current
knowledge of HIV-host interactions influenced by PTMs with a special focus on
acetylation, ubiquitination, and phosphorylation of proteins linked to cellular signaling
and viral replication. Insights into these interactions are surmised to aid development of
new intervention strategies.
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INTRODUCTION
Multiple advances in HIV pharmacotherapy have been made allowing control of viremia,
but not eradication of latent viral reservoirs. To cope this difficulty, new promising efforts
such as gene therapy (Peterson and Kiem, 2017), utilization of broadly neutralizing antibodies
(immunotherapy) (Nishimura and Martin, 2017) or the development of first potential vaccines
(Barouch et al., 2018) have been applied. Nevertheless, it remains a high priority to enhance our
understanding of HIV pathogenesis, latency and persistence in anatomical, immunological and
pharmacological sanctuaries to develop novel drugs/strategies for the treatment and eradication
of HIV.
In the last few years, substantial progress has been made toward understanding of biomolecular
mechanisms underlying the interaction of the virus with the host cell. New methods have allowed
deeper insights into the “rewiring” of cellular pathways by the invading virus. In particular the
identification of PTMs helped to understand how HIV adjusts cell cycle, transcription, translation
or selective degradation of antiviral proteins. The importance of PTMs in HIV infection is
highlighted by several studies that successfully used modifying enzyme inhibitors for reduction
of viral load or reactivation of latent virus. Examples are the use of proto-oncogene tyrosine-protein
kinase Src (SRC)- or lysine-deacetylase inhibitors (Shirakawa et al., 2013; McCarthy et al., 2014).
However, despite the significance of PTMs for HIV, a comprehensive overview of PTM-based
HIV-host interactions is missing so far.
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In this review, we attempt to summarize current knowledge
of modification-controlled processes during HIV replication,
emphasizing several key interactions among viral and cellular
components. Given the broad scope and the overwhelming
amount of available data, we chose to focus on PTM-
related interactions, which might be of greater interest.
Thus, we spotlight on protein acetylation, ubiquitination, and
phosphorylation events (Figure 1A) and their respective role
within the different steps of the viral life cycle. As main
foundation and data source, we made use of the NCBI HIV
Human Interaction Database (HHID) (Ako-Adjei et al., 2015),
which harbors more than 8000 interactions and more than
6800 corresponding publications. Notably, some of the described
interactions are derived from systems-wide mass spectrometry
and next generation sequencing approaches that still require
experimental confirmation. Nonetheless, in combination with
orthogonal methods and experimental/clinical observations, they
provide an exceptional overview of the intricate relationship
between HIV and the human host.
PTMs AND HIV LIFE CYCLE – A CLOSE
INTERRELATIONSHIP
To gain a first overview of the interactions between HIV and
the host-related PTM machinery, we searched HHID (Ako-Adjei
et al., 2015) and cross-correlated data with other data repositories
to identify interactions of HIV proteins with post-translational
modifying enzymes.
For identification of human acetyltransferases and deace-
tylases, we utilized the HUGO Gene Nomenclature Committee
(HGNC) database1, resulting in eleven lysine- and N-terminal-
acetyltransferases out of 40 listed (28%) and eight lysine
deacetylases (KDACs and sirtuins) out of 18 (44%). In case
of E3 ubiquitin ligases, the NHLBI ESBL human E3 ubiquitin
ligases database (Medvar et al., 2016) served as data source
and correlation with the HHID showed interaction with 95
E3 ligases out of 377 (25%). The Ubiquitin and Ubiquitin-like
Conjugation Database (UUCD) (Gao T. et al., 2013) revealed
overall 18 deubiquitinating enzymes (DUBs) out of 103 (17%),
which have been identified so far for HIV-related interactions.
The most comprehensive data were achieved for protein kinases2
(Manning et al., 2002) and phosphatases3 (Duan et al., 2015), as
phosphorylation has been more extensively studied. Here, 219
kinases out of 538 (41%) and 57 phosphatases out of 227 (25%),
respectively, turned out to be influenced during the HIV life
cycle (Figure 1B). Further analysis of the various datasets and
the HIV interaction repository indicated several viral hubs, which
extensively modulate the human host PTMome. To mention
some of them, HIV-1 envelope glycoprotein 120 (GP120) has
been found to interact or functionally alter 118 enzymes of
the aforementioned classes, for the HIV-1 trans-activator of
transcription (TAT) 155 enzymes and for the viral protein R
1www.genenames.org
2www.kinase.com
3www.depod.bioss.uni-freiburg.de
(VPR) 73 enzymes (Figure 1C) have been described. Overall, the
HHID lists so far 138 acetyl-, 1899 phospho-, and 359 ubiquitin-
related HIV-host interactions.
In the following chapters, we will dissect some important
interactions considering the different steps of the viral life cycle –
from viral entry to budding of newly generated virions.
Virus Binding
The initial step of HIV infection depends on adhesion of the
virion to the target host cell and subsequent fusion of viral and
host cell membranes. Whereas initial binding of virus particles to
the host cell is a relatively unspecific process and relies mainly
on weak protein-protein interactions, the second step consists
of a highly controlled sequence of events that are crucial for
virion entry (Figure 2A). Thereby, the HIV envelope (ENV) spike
complex, consisting of glycoprotein 41 (GP41)/GP120 trimers,
binds to the T-cell surface glycoprotein CD4 (CD4) receptor on the
host cell. Subsequently, conformational changes of ENV/GP120
subunits allow binding to the coreceptors C-C chemokine receptor
type 5 (CCR5) or C-X-C chemokine receptor type 4 (CXCR4)
(Maddon et al., 1986; McDougal et al., 1986). During this
process, HIV already modulates multiple intracellular signaling
cascades in a PTM-specific manner by mimicking chemokine
signaling through binding to their cognate receptors (Wu and
Yoder, 2009). Most of these modifications result in the highly
dynamic (re-)organization of the cytoskeleton (Figure 2A). One
can assume that these rearrangements are necessary to allow not
only fusion of the viral particle with the cell, but also prepare
for later intracellular transport. As an example, G-protein related
downstream signaling pathways are activated upon virus binding
affecting e.g., the cytoskeleton structure, cytokine production
and T-cell activation (Abbas and Herbein, 2014). Stimulation
of lymphocytes with GP120 activates mitogen-activated protein
kinase 1 and 3 (MAPK1/3) via dual specificity mitogen-activated
protein kinase kinase 1 (MAP2K1) as well as protein-tyrosine
kinase 2-beta (PTK2B) by interaction with glycosphingolipids
(Viard et al., 2003). Activation of the PTK2B signaling pathways
finally leads to rearrangements of the cytoskeleton (Abbas and
Herbein, 2014). Concurrently, stimulation of MAPK1/3 triggers
e.g., survival of the T-cell. Notably, the MAPK-pathway is
not activated in quiescent T-cells or non-proliferating CD4
T-cells, and thus its induction is dependent on the activation
state of the target T-cell (Kinet et al., 2002). Additionally,
ENV/GP120 induces phosphorylation of the SRC-family member
tyrosine-protein kinase Lck (LCK) (Juszczak et al., 1991;
Deng et al., 2016), which stimulates nuclear translocation of
transcription factor p65 (RELA; also known as NF-κB) (Flory
et al., 1998), being required for later HIV-1 long terminal
repeat (LTR)-dependent transcription. LCK activation induces
phosphorylation of tyrosine kinase ZAP-70 (ZAP70) as well as of
numerous cellular substrates leading to the depletion of cortical
F-actin underneath the virological synapse to ease transmission
of the viral core to the nucleus after viral entry (Vasiliver-
Shamis et al., 2009; Len et al., 2017). Moreover, LCK activates 1-
phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1
(PLCG1), resulting in upregulated Ca2+ flux and activation of
the transcription factor nuclear factor of activated T-cells (NFAT)
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FIGURE 1 | HIV-related PTMome – an overview. (A) Schematic illustration of protein modifications discussed in this review. Proteins can be modified by different
enzymes, which either introduce a functional group (“writers”) or remove it (“erasers”). Thereby, lysine acetylation is achieved by lysine-acetyltransferases (KATs) and
the backward reaction is fulfilled by lysine deacetylases (KDACs, also known as histone deacetylases (HDACs)) or sirtuins. Lysines can be also modified by ubiquitin
in presence of E1 ubiquitin-activating-, E2 ubiquitin-conjugating-enzymes, and E3 ubiquitin ligases. Reversal of ubiquitin linkages is achieved by deubiquinating
enzymes (DUBs). Another frequent modification occurs at serine-/threonine- and/or tyrosine-residues, where phosphate groups are transferred to by kinases.
Removal of phosphorylation is carried out by phosphatases. All three modifications can influence each other and might occur at the same protein. (B) HIV interacts
with several modifying enzymes. Based on the NCBI HIV interaction database, several interactions of viral proteins with modifying enzymes have been described.
Shown here are six groups of writers and erasers, which interact in one way or another with HIV during the viral lifecycle. The graph provides the percentage (number
in circle) of interacting enzymes of a respective class in comparison to the amount of enzymes of the same class found in the human proteome. Number of all
enzymes of a class is given on the right site and is based on the HNGC database, the National Heart Lung and Blood Institute ESBL human E3 ubiquitin ligases
databank, The Ubiquitin and Ubiquitin-like Conjugation Database (UUCD), and databases for protein kinases2 and phosphatases (DEPOD)3. Notably, for acetylation
not only lysine-acetyltransferases but also N-terminal acetyltransferases were included. (C) Schematic overview of viral proteins interacting with modifying enzymes.
The graph depicts the number of interactions of different HIV proteins with kinases/phosphatases, KATs/KDACs, and E3 ligases/DUBs. Number of interactions is
provided in form of a heat map.
(Abbas and Herbein, 2014). This way not only several cytokines
like interleukin 2 (IL2) are expressed, which trigger activation of
the T-cell, but also viral replication in sub-optimally activated
cells might be promoted (Cicala et al., 2006). Within the context
of actin rearrangements, binding of GP120 to CXCR4 also
triggers transforming protein RhoA (RHOA) and Ras-related C3
botulinum toxin substrate 1 (RAC)-dependent pathways causing
phosphorylation of actin severing factor cofilin-1 (CFL1) by
LIM domain kinase (LIMK), and thus the transient inactivation
of CFL1 (Jiménez-Baranda et al., 2007). Consequently, actin
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FIGURE 2 | Interaction networks of HIV and host proteins during early steps of infection. (A) Binding of HIV to the host cell. Binding of the viral envelope GP160
complex, consisting of GP120 and GP41, to CD4 as well as the co-receptors CXCR4 or CCR5 results in activation of several protein kinases. Thereby, the
cytoskeleton becomes rearranged, which favors entry and subsequent nuclear import of the virus. The network displays an overview of relevant interactions. Black
arrows indicate activating effects and red “inhibitory”-arrows indicate inhibitory effects. Kinases are depicted in dark blue, phosphatases in light blue, KATs in dark
red, KDACs in light red, E3 ligases in dark yellow, and DUBs in light yellow. Other host proteins are colored white, whereas viral proteins are presented in gray.
(B) Uncoating and reverse transcription. The graph illustrates several protein-protein interactions that have been described during uncoating and reverse
transcription. Please note that VPX is only expressed in HIV-2 and SIV but not in HIV-1. CRL4 complex consists of cullin4A (CUL4A), DNA damage binding protein 1
(DDB1), RING H2 finger protein (RBX1) and the DDB1 and CUL4-associated Factor 1 (DCAF1). Figure legend as in A. More detailed information can be found in the
text.
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remodeling is reduced which might contribute to a more
efficient receptor clustering (Stolp and Fackler, 2011). In the
subsequent steps during virus entry, a rapid switch from an
inactivated to an activated state of CFL1 by dephosphorylation is
established, which may involve several phosphatases, like protein
phosphatase slingshot homolog 1-3 (SSH1-3), pyridoxal phosphate
phosphatase (PDXP), serine/threonine-protein phosphatases PP1-
alpha (PPP1CA) and PP2-alpha (PPP2CA) (Wu et al., 2008).
Activated CFL1 induces actin polymerization, which might
contribute to overcome static actin restriction and to block
CXCR4 internalization (Yoder et al., 2008; Spear et al., 2012).
Previous studies identified other actin-related factors, such as
the cytoskeletal crosslinking factor proteins ezrin (EZR), radixin
(RDX) and moesin (MSN) (also named together ERM), that show
increased phosphorylation upon interaction of HIV ENV/GP120
with CXCR4 or CCR5. However, the distinct roles of ERM
proteins on the early phase of HIV-1 replication have been
controversial, as positive (Kubo et al., 2008; Barrero-Villar et al.,
2009) and negative (Naghavi et al., 2007; Capalbo et al., 2011)
effects on HIV have been described.
Besides several phosphorylation events, lysine (de-)acetyla-
tion has been also identified as a regulating PTM for the
reorganization of the cytoskeleton: Binding of ENV/GP120 to
CD4 induces the formation of acetylated α-tubulin which is
involved in stabilization of microtubules and thus fosters HIV
infection (Piperno et al., 1987; Valenzuela-Fernández et al., 2005;
Sabo et al., 2013). Conversely, cytosolic histone deacetylase 6
(HDAC6) has been found to counteract tubulin acetylation and
thereby suppressing infection by HIV (Valenzuela-Fernández
et al., 2005). An overview of the described events is given in
Figure 2A.
Fusion, Uncoating and Reverse
Transcription
Conformational changes finally cause dissociation of GP120 from
GP41 and the transition of GP41 into its fusogenic state. It is
believed that a so far not completely understood combination
of interactions finally leads to the formation of the GP41 six-
helix bundle and along with that the fusion of the virion with
the host cell membrane. Interactions are surmised to include
GP41, virus- and target cell-proteins, accompanied cytoskeletal
rearrangements (as discussed in more detail in the previous
chapter), and lipids.
As soon as the virus has entered the cell, its conical
capsid core is released into the cytoplasm. At this time point,
reverse transcription of the viral RNA into double-stranded
cDNA is initiated (Figure 2B). Concurrently, dissociation of the
protective, conical capsid surrounding the HIV1 genome occurs,
a process known as uncoating. However, the detailed spatial and
temporal steps of uncoating and reverse transcription remain
unsolved. Three potential models for the uncoating process
of HIV-1 have been advanced so far [for further information
of the uncoating process, we would like to refer to a review
from (Campbell and Hope, 2015)]. In brief, the “immediate
uncoating” model describes the rapid disassembly of the viral
core shortly after membrane fusion (Miller et al., 1997; Fassati
and Goff, 2001). Thereby, the reverse transcription complex
(RTC), consisting of viral reverse transcriptase (RT), integrase
(IN), viral RNA and newly synthesized viral DNA, exists freely
in the cytoplasm loosely surrounded by viral capsid proteins
(CA/P24) and is transported toward the nucleus. Several findings
suggest that CA/P24 as well as the capsid core itself provide
critical functions for reverse transcription of viral RNA and its
nuclear transport promoting two other models of uncoating.
In the first model the core remains associated with the RTC
(Perez-Caballero et al., 2005; Hulme et al., 2011; Lukic et al.,
2014), mediating the interaction with host factors and the nuclear
import (“cytoplasmic uncoating”). In the second model the
core stays intact until arrival at a nuclear pore complex (“NPC
uncoating”), preventing detection of viral double-stranded DNA
by cytosolic DNA sensors like the cyclic GMP-AMP synthase
(CGAS) (Gao D. et al., 2013; Hilditch and Towers, 2014). The
later model is further supported by the recent discovery of
dynamic capsid pores for nucleotide import (Jacques et al., 2016).
Independent of the respective model, it is believed that the
disassembly of the viral core underlies a controlled reaction. It
has been demonstrated that the RTC/pre-integration complex
(PIC) as well as parts of the capsid are transported via the
microtubule network toward the nucleus (McDonald et al.,
2002; Fernandez et al., 2015). Experimental evidence has been
reported that CA/P24 as well as the capsid core structure
harbor critical functions for reverse transcription, uncoating, and
nuclear localization.
Several of these functions are regulated via PTMs (Figure 2B).
As an example, CA/P24 becomes phosphorylated at three serine
residues (S109, S149, S178) affecting the reverse transcription
process (Cartier et al., 1999). Interestingly, the function of
virions carrying mutated serine residues S149 and S178 could
be rescued by pseudotyping the virus with vesicular stomatitis
virus glycoprotein (VSV-G) to bypass HIV envelope fusion
(Brun et al., 2008). Takeuchi and colleagues recently identified
maternal embryonic zipper kinase (MELK) to be responsible for
at least phosphorylation of serine S149 and this modification
appears to be critical for optimal uncoating and viral cDNA
synthesis (Takeuchi et al., 2017). Other studies identified MAPK1
to mediate phosphorylation of serine S16 of CA/P24 and
the regulation of peptidyl-prolyl cis-trans isomerase NIMA-
interacting-1 (PIN1)-dependent uncoating (Misumi et al., 2010;
Dochi et al., 2014). The spatiotemporal interaction of MAPK1
with CA/P24 is under debate, as MAPK1 has also been identified
as virion associated protein kinase. Low level activity of MAPK1
might already exist within the virion and is expected to be
enhanced by stimuli accompanied with binding and fusion of the
virion to its target cell (Bukrinskaya et al., 1996; Cartier et al.,
1999).
Parallel to the uncoating of the viral core, the reverse
transcription of the viral genome takes place (Figure 2B). This
process is regulated by several protein-protein interactions as
well as PTMs critical for efficient viral cDNA generation. In
addition, PTMs are important to counteract transcription by
activation/modulation of several host restriction factors. During
the binding of the virion to the host cell, interactions with
the CD4 receptor as well as the co-receptors CXCR4 or CCR5
induce the Gαi-dependent MAPK pathway via phosphorylation,
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which facilitates reverse transcription (Mettling et al., 2008).
Moreover, several other modifications have been demonstrated
to be required after fusion for modulation of RT activity.
In this context, host cyclin-dependent kinases (CDKs) have
been identified as influencers of RT activity. As an example,
CDK2 directly phosphorylates RT on tyrosine residue T216,
thereby increasing its efficacy and stability (Leng et al., 2014).
Interestingly, phosphorylation of T216 was abolished by cell-
intrinsic CDK2 inhibitor cyclin-dependent kinase inhibitor 1A
(CDKN1A, also known as P21), which has been shown to be
upregulated in “elite-controller” patients (Chen et al., 2011; Sáez-
Cirión et al., 2011; Leng et al., 2014).
Moreover, casein kinase II (CSK2) has been shown to be
responsible for RT phosphorylation, as investigated in HIV-1
infected MOLT-4 cells (Ohtsuki et al., 1998). Phosphorylation
of purified RT in vitro by several kinases including CSK2
was also shown by the group of S. Wilson (Idriss et al.,
1999). The significance of RT phosphorylation by CSK2
was further corroborated by another study, demonstrating
that the different molecular functions (RNA-, DNA-dependent
polymerase, ribonuclease H) of RT were stimulated in vitro via
CSK2-dependent phosphorylation (Harada et al., 1999).
Reverse Transcription and Antiviral
Restriction
HIV evolved direct and indirect ways to counteract host cellular
restriction factors that block viral RT activity (Figure 2B).
For instance, HIV-1-induced lymphopenia is associated with
increased levels of interleukin 7 (IL7) (Napolitano et al.,
2001). IL7 is able to induce phosphorylation of deoxynucleoside
triphosphate triphosphohydrolase SAMHD1 (SAMHD1) via the
cyclin A2 (CCNA2)/ cyclin dependent kinase 1 (CDK1) complex
(Cribier et al., 2013; Coiras et al., 2016), resulting in the loss of
SAMHD1’s ability to restrict reverse transcription via reduction
of the intracellular pool of dNTPs (Lahouassa et al., 2013).
Notably, phosphorylation and dephosphorylation of SAMHD1
as well as its overall expression levels are modulated also
independently of IL7 throughout the cell cycle. SAMHD1 is
highly expressed during quiescence (G 0 phase) but minimally
expressed and present in an phosphorylated, inactive state during
replication (S phase) (Sze et al., 2013).
Besides the indirect control of SAMHD1 via IL7, several
simian immunodeficiency virus (SIV) groups and their closely
related HIV-2 counterparts carry the accessory viral protein
X (VPX) (which is missing in HIV-1) for directly targeting
SAMHD1 (Laguette et al., 2011; Hofmann et al., 2012).
Thereby, VPX interacts with the cullin4A (CUL4A)/ DNA
damage binding protein 1 (DDB1) and CUL4-associated Factor
1 (DCAF1) complex (CRL4 complex), leading to ubiquitination
and subsequent proteasomal degradation of SAMHD1. VPX
induced degradation of SAMHD1 might not only affect the
cytosolic dNTP pool, but is suggested also to influence the
concentration of nuclear dNTP levels required for gap repair in
HIV integration. Moreover, it prevents SAMHD1’s ability to bind
long RNAs/single-stranded DNA, which might as well restrict
reverse transcription (Seamon et al., 2016).
Another host restriction factor counteracted by HIV within
this process is DNA dC −> dU-editing enzyme APOBEC-
3G (APOBEC3G). APOBEC3G exerts a multifaceted inhibition
scheme against reverse transcription as it deaminates cytosine
residues to uracil in viral minus strand DNA, resulting in
hypermutations of the provirus (Harris et al., 2003; Bishop
et al., 2004). This activity of APOBEC3G is so effective that
even a single incorporated APOBEC3G-unit is likely to cause
extensive and inactivating levels of HIV hypermutations (Zhang
et al., 2003; Armitage et al., 2012). Concurrently, APOBEC3G
significantly inhibits RT-catalyzed DNA elongation (Iwatani
et al., 2007). Here, the HIV-accessory protein virion infectivity
factor (VIF) induces polyubiquitination and subsequental
proteasomal degradation of APOBEC3G via recruitment of the
cullin-5 (CUL5)- SKP, Cullin, F-box containing (SCF) complex
(Yu, 2003; Goncalves and Santa-Marta, 2004). Simultaneously,
VIF is in turn degraded by the host: The E3 ubiquitin-protein
ligase Mdm2 (MDM2) was reported to post-translationally
modify VIF, thus targeting it for proteasomal destruction (Izumi
et al., 2009).
Similarly, HDAC6 can antagonize VIF activity by promoting
autophagic clearance of the viral accessory protein via its
deacetylase activity. Additionally, there is evidence that HDAC6
is able to reduce the amount of VIF incorporated into nascent
virions and thus affects infectivity of HIV particles. Moreover,
HDAC6 directly binds to and stabilizes APOBEC3G, resulting
in impaired reverse transcription (Valera et al., 2015). In
contrast to the mentioned restrictive effect of HDAC6 on
reverse transcription, another deacetylase has been identified
to be required for reverse transcription. Yeast-two-hybrid
screening identified histone deacetylase complex subunit SAP18
(SAP18) and components of the paired amphipathic helix protein
Sin3a (SIN3A)-histone deacetylase 1 (HDAC1) complex to be
interacting with IN (Sorin et al., 2009). Further experiments
revealed incorporation of HDAC1 into newly formed
HIV-1 virions and showed that enzymatically inactive mutants
of HDAC1 result in a block of early reverse transcription.
Another example of antiviral defense of the host cell is the
activation of protein tyrosine kinases shortly after binding of the
virus. Two of these kinases are SRC and PTK2B, which are known
to interact with each other. Experiments with kinase inhibitors
and RNA interference targeting SRC in human T-cells revealed
increased HIV-1 reverse transcription, genomic integration, and
subsequent gene transcription. Thus, activation of SRC might be
part of a cellular response system to prevent or at least slow down
infection (McCarthy et al., 2014).
In summary, all in this chapter and the one before mentioned
examples (please see also Figure 2B) demonstrate the impact
of PTMs on the early steps of viral infection, where both,
virus and host make use of specific modifications to modulate
protein machineries and signaling pathways to either support or
counteract reverse transcription.
Nuclear Import and Integration
Within the course of uncoating and reverse transcription
of the viral single-stranded RNA, newly synthesized DNA
associates/remains associated with viral and cellular proteins
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forming the preintegration complex (PIC). The PIC consists
of the newly transcribed viral cDNA, The viral proteins IN,
RT, VPR, and HIV matrix protein (MA/P17) as well as an
incompletely characterized group of host factors (Fassati and
Goff, 2001; Lin and Engelman, 2003; Llano et al., 2004b;
Iordanskiy et al., 2006; Raghavendra et al., 2010; Matreyek
and Engelman, 2013). Utilizing the cellular nuclear import
machinery, HIV cDNA as part of the PIC is actively delivered into
the nucleus for subsequent integration and productive infection.
As a consequence, HIV can successfully replicate even in non-
dividing, cell-cycle arrested cells (Lewis et al., 1992) and in
terminally differentiated cells like macrophages or dendritic cells
(Gabuzda et al., 1986; Patterson and Knight, 1987; Weinberg
et al., 1991; Pope et al., 1994; Reece et al., 1998).
The PIC’s route into the nucleus is accompanied by several
tightly regulated PTM-based interactions, which will be discussed
within this chapter based on different examples (see also
Figure 3). The first example is the kinesin-1 adaptor fasciculation
and elongation protein zeta-1 (FEZ1), which is exploited by the
HIV-1 capsid for its movement into the nucleus (Malikov et al.,
2015). It has been shown that FEZ1 and kinesin-1 heavy, but
not light chains affect not only HIV-1 transport, but also the
uncoating process. Thereby, the capsid binds serine/threonine-
protein kinase MARK2 (MARK2, also known as microtubule
affinity regulating kinase 2) to stimulate FEZ1 phosphorylation
(Malikov and Naghavi, 2017).
Another, highly modified and extensively examined protein
in this context is IN, which is involved in different steps of
HIV replication such as reverse transcription, nuclear import,
genomic integration and also later on in virion packaging.
Recently, eukaryotic translation initiation factor-2-alpha kinase
4 (EIF2AK4, also known as GCN2) has been identified as a
general restriction factor of lentiviral DNA integration (Jaspart
et al., 2017). Infection with HIV-1 triggers acute decrease in
protein translation by phosphorylation and thereby activation
of EIF2AK4. Moreover, EIF2AK4 directly interacts with IN
causing phosphorylation of serine S255 in its C-terminal domain
(CTD), which decreases efficiency of viral DNA integration.
Antiviral activity of EIF2AK4 is counteracted by HIV-1 and
HIV-2 proteases (PR), which cause proteolytic cleavage of
EIF2AK4 and thus abrogate activation of EIF2AK4 by viral
RNA (del Pino et al., 2012; Cosnefroy et al., 2013; Jaspart
et al., 2017). In activated T-cells, IN becomes phosphorylated
on serine S57 by cellular c-Jun N-terminal kinase (JNK).
Subsequently, phosphorylated IN is conformationally modified
by peptidylprolyl cis/trans isomerase, NIMA-interacting 1 (PIN1),
which stabilizes IN (blockade of ubiquitination and associated
proteasomal degradation) and seems to be required for efficient
genomic integration. Lack of this modification restricts viral
infection in non-activated/resting CD4 T-cells (Manganaro et al.,
2010).
Using the translation inhibitor cycloheximide, as well
as proteasome inhibitor MG132, it was demonstrated that
IN, overexpressed as single protein in HEK293T cells, is
relatively unstable and is poly-ubiquitinated for proteasomal
degradation (Mulder and Muesing, 2000). Another study
identified the prefoldin subunit 3 (VBP1, also known as PFDN3 or
von Hippel-Lindau-binding protein 1) as interacting protein, that
bridges IN and cullin-2 (CUL2)-related von Hippel-Lindau disease
tumor suppressor (VHL) ubiquitin E3 ligase for degradation
(Mousnier et al., 2007). Interestingly, degradation seems to be
important for later viral replication as a 60% reduction of
released infectious particles was observed mutating degradation-
relevant lysines K211, K215 and K219 (Mousnier et al., 2007).
Degradation of IN is circumvented by different host cell proteins:
e.g., PC4 and SFRS1-interacting protein (PSIP1, also known as
LEDGF) was identified as interacting with IN and blocking VHL-
based degradation (Cherepanov et al., 2003; Llano et al., 2004a).
Other approaches identified human E3-ubiquitin protein ligase
RAD18 (RAD18) as well as X-ray repair cross-complementing
protein 6 (XRCC6), both known for their role in DNA repair,
as IN stabilizing factors (Mulder et al., 2002; Zheng et al.,
2011). However, the exact roles of RAD18 and XRCC6 in HIV
replication remain elusive.
Besides ubiquitination, IN has been shown to be modified
by small ubiquitin-like modifier (SUMO), a PTM that is
involved in various cellular processes including the transport
between cytosol and nucleus or the transcriptional regulation.
Several conserved lysine residues of IN were analyzed to have
an impact on HIV-1 replication after reverse transcription,
but before genomic integration (Zamborlini et al., 2011).
The researchers hypothesized that these modifications might
regulate interactions with different co-factors, harboring sumo-
interacting motif (SIM) domains, like tripartite motif-containing
protein 5 alpha (TRIM5A). This notion is also supported by
findings that IN-interacting proteins like PSIP1 or RAD18 are
involved in SUMO-related protein-protein complexes (Bueno
et al., 2010; Despras et al., 2016). Furthermore, overexpression
of SUMO1/SUMO2 and SUMO-conjugating enzyme UBC9
(UBE2I) perturbed intracellular localization of IN and influenced
integration of HIV-1, while reverse transcription and nuclear
import of the PIC remained unaffected (Li et al., 2012).
Immuno-precipitations and fluorescence resonance energy
transfer (FRET) experiments revealed another modification of
IN – namely lysine-acetylation by histone acetyltransferase p300
(EP300) at lysine residues K264, K266, and K273 (Cereseto et al.,
2005). Acetylation increased the affinity of IN to DNA and
promoted its ability for DNA strand transfer. The importance
of lysine-acetylation was further demonstrated by acetylation-
incompetent mutants, which caused a suppression of viral
integration capacity. The same group as well identified the
histone acetyltransferase KAT2A (KAT2A, also known as GNC5)
as interactor and modifier of IN (Terreni et al., 2010). KAT2A-
related acetylation of IN enhanced its 3′-end processing and
strand transfer activity. Knockdown of KAT2A markedly reduced
HIV-1 infectivity. Interestingly, KAT2A targets the same lysines
as EP300 with exception of K258, which is acetylated by KAT2A
only. Notably, importance of IN acetylation was questioned by
lysine to arginine mutations of the three lysines, controlled
by EP300 and KAT2A, since the mutated viruses were still
replication-competent (Topper et al., 2007).
A yeast-two-hybrid screen identified, amongst others,
PSIP1, transcription intermediary factor 1-beta (TRIM28, also
known as TIF1B), transcription factor BTF3 (BTF3B), thyroid
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FIGURE 3 | Nuclear import and genomic integration. The graphic illustrates the influence of post-translational modifying enzymes on the nuclear transport of the PIC
and the integration of the viral cDNA into the host genome. Figure legend as in Figure 2A. More detailed information can be found in the text.
hormone receptor-associated protein 3 (THRAP3), non-histone
chromosomal protein HMG-17 (HMGN2), ran-binding protein
9 (RANBP9), and exportin-2 (EXP2) as binding partners of
acetylated IN (Allouch and Cereseto, 2011). Further experiments
confirmed direct binding of TRIM28 to IN and demonstrated
recruitment of HDAC1, which resulted in deacetylation of IN.
TRIM28 seems to reduce IN-dependent genomic integration and
thus restricts HIV-1 infection (Allouch et al., 2011). Acetylation
has been implicated in the process of post-integration repair.
The group of R. Daniel was able to show that, on the one hand,
histone deacetylase 4 (HDAC4) associates with viral DNA in
an IN-dependent manner and, on the other hand, seems to be
required for efficient transduction by HIV-1-based vectors in
cells that are deficient in other DNA repair proteins (Smith and
Daniel, 2006; Smith et al., 2010). Further research is required
to clarify the impact of lysine acetylation in IN activity and in
general on HIV infection.
Besides IN, other viral protein functions are PTM-modulated
during the integration process of HIV-1. For instance, the
MA/P17 is phosphorylated on tyrosine Y132 by a not further
characterized virion-associated cellular protein kinase, which
targets MA/P17 to the nucleus during transversion of the PIC.
Interestingly, viruses carrying MA/P17 tyrosine mutants grow
normally in dividing cells, but are blocked for nuclear import
in terminally differentiated cells like macrophages (Gallay et al.,
1995). MA/P17 interacts with protein kinase C (PRKC) resulting
in phosphorylation of serine residue S111 (Burnette et al., 1993).
Phosphoaminoacid and phosphopeptide analysis also revealed
phosphorylation of other serine-residues of MA/P17 – especially
in nuclear fractions of infected cells (Bukrinskaya et al., 1996).
However, the time and exact role of MA/P17 phosphorylation in
the context of nuclear import and integration is still controversial
as two reports indicated that its phosphorylation predominately
occurs before virion entry (Gallay et al., 1995; Bukrinskaya et al.,
1996).
An intriguing link between integration and pathogenesis
was suggested by a study showing that infection by wild-type
HIV-1, but not an integrase-deficient mutant, induced the death
of activated primary CD4 T-lymphocytes. The mechanism of
killing involves activation of DNA-dependent protein kinase
(PRKDC), a central node of the cellular DNA damage
response system. Activated PRKDC phosphorylates histone
H2AX (H2AFX) and cellular tumor antigen p53 (TP53), which
subsequently can trigger apoptosis (Cooper et al., 2013).
Although the study was controversially discussed (Estaquier et al.,
2013), it underscores the far-reaching PTM-based modulations
within the cell during viral integration.
Within the context of DNA damage recognition and repair,
a study testing the effect of DNA-repair inhibitor caffeine on
HIV-1 infection, found evidence for ATM and Rad3-related
kinase (ATR) being required to successful complete genome
integration (Daniel et al., 2003).
The accessory protein VPR is packaged into newly produced
virions and plays an important role for early steps in de novo
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viral infection. VPR harbors a series of C-terminal serines (S79,
S94, and S96), which have been identified to be important for
its nuclear localization and viral replication in macrophages
(Agostini et al., 2002). These serines were found to be
phosphorylated as assessed by an alanine screen. Phosphorylation
of serine residue S79 by cAMP-dependent protein kinase (PRKA)
affects cell cycle progression (Zhou and Ratner, 2000; Barnitz
et al., 2010) and combined mutation of all three serines decreased
HIV-1 replication in macrophages (Zhou and Ratner, 2000).
Notably, the replication defect was shown to be due to an
inefficient nuclear import of viral cDNA as demonstrated by
reduced levels of 2-LTR circles (Agostini et al., 2002).
Overall, viral integration is controlled by a multitude of post-
transcriptional modifications (Figure 3) that modulate function
of viral and host cell proteins, thereby affecting enzymatic
activity, protein-protein interaction or subcellular localization of
integration- related proteins.
Transcription and Latency
After integration of the viral cDNA into the host genome, the
LTR-flanked provirus behaves like a cellular gene, where the 5′-
LTR serves as a promoter and the 3′-LTR as polyadenylation-
and termination-site. Single-molecule amplification and long-
read sequencing revealed that transcription from the 5′-LTR
results in the generation of one primary transcript, which is
further spliced into at least 109 different mRNAs (Ocwieja et al.,
2012). Depending on the cell-cycle, activation state of the infected
cell, integration site, and other factors, HIV either continues to
express (Figure 4A) or becomes latent (Figure 4B). As both
processes are interconnected and highly modulated/influenced
by post-translationally modified host factors and viral proteins,
we will dissect both events to allow a more detailed view on
the molecular mechanisms associated with either latency or viral
gene expression.
Transcription
Immediately after successful integration into the host
chromosome, the HIV genome becomes regulated by cellular
transcription factors and some viral proteins. The transcription
pre-initiation complex, harboring a complex composition of
proteins like RNA Polymerase II and some transcription factors,
binds to enhancer elements within the 5′-LTR and accumulates
more essential host transcription factors like RELA (Nabel and
Baltimore, 1987), NFAT (Kadonaga et al., 1986), and transcription
factor SP1 (SP1) (Jones et al., 1986) to the viral promoter region.
At the beginning, a relatively small number of fully spliced
RNA transcripts is generated, which encode for the regulator
of expression of viral proteins (REV) and the trans-activator of
transcription (TAT). Subsequently, both proteins are shuttled
to the nucleus where they are required for the regulation of
viral gene expression and mRNA transport into the cytosol.
As long as TAT is absent, transcriptional initiation at the LTR
is efficient – however, successful transcription is prevented as
the polymerase will either disengage from the DNA template
or is stalled in a concerted action of the negative elongation
factors (NELFs), transcription elongation factor SPT5 (SUPT5H)
and NELF. Following binding of TAT to the HIV-related RNA
stem-loop structure transactivation response element (TAR)
(Dingwall et al., 1990), the positive transcription elongation
factor b (PTEFB), consisting of the cyclin-dependent kinase
9 (CDK9) and cyclin-T1 (CCNT1), is recruited to the RNA
polymerase II (RNAPII) complex (Garber et al., 1998; Zhou et al.,
2000). Thereby, functional capacity of RNAPII is increased and
efficient elongation of transcripts is initiated.
Several of these steps are modulated and fine-tuned by
the interplay of PTM modifying enzymes, PTM-interacting
proteins, and the viral/host transcription machinery (Figure 4A).
One of the most studied proteins in this context is the viral
TAT protein, which has been shown to interact with more
than 180 different nuclear proteins by a proteomic screen
(Gautier et al., 2009). Due to this extensive number of complex
interactions, we will focus here only on some PTM-related
interactions of TAT (a more comprehensive overview of TAT-
related interactions is given in Figures 4A,B). TAT shapes
the nuclear acetylome by recruiting several acetyltransferases
(KATs) such as KAT2A/histone acetyltransferase KAT2B (KAT2B)
and EP300/CREB-binding protein (CREBBP) to the 5′-LTR to
enhance transcription (Lusic et al., 2003; Boehm et al., 2013).
Discrete histone regions, on histone 3 (H3) and 4 (H4),
were observed to be acetylated using a quantitative chromatin
immunoprecipitation assay. Along with histone acetylation was
the recruitment of EP300/CREBBP, KAT2B and KAT2A as well
as the transcription factor RELA by TAT (Benkirane et al.,
1998; Lusic et al., 2003). Moreover, it was found that the P50
subunit as well as the P50/P65 complex of RELA were acetylated
by EP300/CREBBP in a TAT-dependent manner. Thereby,
acetylation of P50 increased DNA binding of RELA, which
coincided with increased transcription rates (Furia et al., 2002).
The diverse interactions of TAT are controlled by differential
acetylation of TAT itself (Ott et al., 1999; Brès et al., 2002; D’Orso
and Frankel, 2009). For example, while acetylation of TAT by
EP300 within the TAR binding domain at lysine K50 promotes
dissociation of TAT from TAR RNA – an important process
in the early steps of transcriptional elongation, acetylation of
lysine K28 via KAT2B enhances TAT binding to associated
kinases CDK9/PTEFB (Kiernan et al., 1999; Deng et al., 2000;
D’Orso and Frankel, 2009). Similarly, KAT2A also considerably
enhances the transcriptional activity of TAT by acetylation of
lysines K50/K51 (Col et al., 2001). Interestingly, HDAC6 was
discovered to deacetylate TAT at lysine K28, thereby suppressing
its transactivation ability of the HIV LTR region – a process
that on the first view seems to counteract TAT activity but is in
fact postulated to be important for transcriptional fine-tuning
and RELA activity (Huo et al., 2011). Moreover, it has been
reported that TAT increases HDAC6 expression in astrocytes,
which results in direct regulation of pro-inflammatory genes
(Youn et al., 2015, 2017).
Another complex interaction exists between TAT, the
acetyltransferase histone acetyltransferase KAT5 (KAT5, also
known as TIP60), and the NAD-dependent protein deacetylase
sirtuin-1 (SIRT1). TAT causes proteasomal degradation of KAT5
via EP300/CREBBP, preventing TP53-related apoptosis (Harrod
et al., 2003; Col et al., 2005; Sapountzi et al., 2006) and
additionally disturbing expression of KAT5-dependent genes
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FIGURE 4 | Transcription and latency. (A) The interaction scheme displays protein-protein interactions that have been identified to promote transcription of viral
genes. (B) Likewise, to A, the protein network demonstrates the influence of modifying enzymes onto the latent state of HIV. Figure legend as in Figure 2A.
Additionally, methyl-transferases, depicted in green, are shown. More detailed information can be found in the text.
such as manganese-dependent superoxide dismutase (SOD2), an
enzyme that normally interferes with efficient virus replication
and propagation (Creaven et al., 1999).
However, TAT also inhibits SIRT1, which, in contrast,
enforces acetylation of TP53 and thus promotes apoptosis in the
host cell (Thakur et al., 2012). Moreover, inhibition of SIRT1
results in hyperacetylation of RELA and EP300/CREBBP,
which subsequently leads to activation of RELA-driven
transcription (Blazek and Peterlin, 2008; Pinzone et al.,
2013) and concomitantly to hyperactivation of the T-cell, a
state frequently observed in HIV infected individuals (Kwon
et al., 2008). Interestingly in this context, it has also been
shown that TAT itself requires deacetylation by SIRT1 for a new
binding cycle to the TAR stem-loop, which is necessary for full
transcription (Pagans et al., 2005; Blazek and Peterlin, 2008). In
summary, findings implicate that the interplay between TAT and
SIRT1 requires a fine-tuned spatio-temporal regulation.
Apart from interaction with acetylation-related proteins, TAT
interacts with several kinases and phosphatases in order to
manipulate cellular pathways. As described before, TAT actively
recruits CDK9 and CCNT1 (PTEFB complex) to the TAR
RNA loop and induces phosphorylation of serine S5 of the
CTD of RNAPII, which enhances co-transcriptional capping of
HIV-1 RNA (Herrmann and Rice, 1993; Yang et al., 1996;
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Zhou et al., 2003). Additionally, CDK9 is recruited to
phosphorylate SUPT5H and NELF, thereby alleviating their
repressive effect on transcription elongation (Yamaguchi et al.,
1999; Rice, 2016). Other CTD kinases like CDK2 and cyclin-
dependent kinase 7 (CDK7) were also reported to be activated
by TAT for further phosphorylation of RNAPII (Cujec et al.,
1997; Furia et al., 2002). Interestingly, activity of TAT in
return seems to be dependent e.g., on phosphorylation of serine
residues S16/S46 by the CDK2/G1/S-specific cyclin-E1 (CCNE1)
complex as shown in in vitro and in cellula experiments.
Mutation of both serines reduced HIV-1 transcription and
inhibited viral replication in transiently transfected cells (Deng
et al., 2002; Ammosova et al., 2006). Simultaneously, TAT
activation of CDK9 is counteracted by serine/threonine-protein
phosphatase PP1-alpha catalytic subunits PPP1CA and PPP2CA,
which cause destabilization of the PTEFB-TAT transactivation
complex (Ammosova et al., 2005; Tyagi et al., 2015). TAT
has also been shown to induce phosphorylation of SP1 via
PRKDC (Chun R.F. et al., 1998). Concurrently, TAT prevents
dephosphorylation of SP1 by transcription factor TCF4 (TCF4)
in astrocytes as demonstrated by biochemical characterization
(Rossi et al., 2006). Another important interaction has been
determined between TAT and the interferon (IFN)-induced,
double-stranded RNA-activated protein kinase (EIF2AK2). TAT
competes with EIF2AK2’s usual substrate, the elongation factor
2 (EEF2) and thereby circumvents the IFN-induced translation-
block within the host cell. Moreover, interaction with EIF2AK2
results in phosphorylation-dependent enhancement of TAT-
based transcription (Endo-Munoz et al., 2005).
As the interplay of TAT with acetylation- and
phosphorylation-related proteins for transcriptional fine-
tuning and viral amplification has been documented in a
variety of experiments, only a small number of interactions
with ubiquitin or other PTM modifiers (e.g., SUMO) has been
discovered so far. A classical function of ubiquitination is the
general protein turnover via proteasomal degradation. Li and
colleagues (Zhang et al., 2014) showed that TAT undergoes K48-
linked ubiquitination, targeting it to proteasomal degradation.
Thereby, TAT’s transactivation activity is modulated. On a more
general look, TAT interacts with several E3 ubiquitin-protein
ligases. As an example, proto-oncogene MDM2 mediates the
ubiquitination of TAT at lysine residue K71 and thus stimulates
the transcriptional properties of TAT (Brès et al., 2003). Recently,
it has been shown that E3 ubiquitin-protein ligase Praja-2
(PJA2) can ubiquitinate TAT in a non-degradative manner and
specifically regulates HIV transcription elongation (Faust et al.,
2017).
Overall, and adding another level of complexity TAT’s
multitude interactions are believed to be tightly regulated at
different steps of the replication cycle and in individual cell types.
Latency
Apart from the active transcription of viral genes described
above, also transcriptionally silent and long-lived cell reservoirs
are established, which remain the major obstacle to HIV-1
eradication as they stay unaffected by anti-retroviral therapy and
are the source of viral rebound upon cessation of antiretroviral
therapy (ART) (Chun et al., 1997; Zaikos and Collins, 2014; Lee
and Lichterfeld, 2016; Colby et al., 2018). Studies have shown
that the reservoir is very stable with a halflife of approximately
more than 3 years (Finzi et al., 1999; Siliciano et al., 2003; Crooks
et al., 2015). It has been proposed that either a clonal expansion
of latently infected cells (Murray et al., 2016) or a persistent low
level replication of HIV-1 are responsible for sustainment of the
reservoir (Lorenzo-Redondo et al., 2016).
Latency itself is a proportionally rare event in the context
of HIV (Siliciano et al., 2003), launching early during acute
infection, likely within the range of days (Chun T.-W. et al.,
1998). The latent reservoir is estimated to exist with a mean
frequency of ∼1/106 resting CD4 T-cells in treated individuals
(Eriksson et al., 2013), but could comprise more cells/cell types as
the reservoir is incompletely defined (Ho et al., 2013). Latently
infected lymphoid cells reside in the host without or very low
expression of viral proteins (Folks et al., 1986; Jordan et al.,
2003), providing a basis for their immune escape. The reason
for the inactive viral state lies mainly in the resting nature
of CD4 T-cells. However, despite its clinical relevance, the
molecular mechanisms that are responsible for establishment and
maintenance of HIV latency remain unresolved. Nevertheless, it
is unquestionable that chromatin remodeling of the integrated
HIV promoter region has to take place as well as epigenetic
silencing and modulation of transcription factor binding to
achieve a latent state (Figure 4B). Analysis of integration
sites in the J-Lat latency cell model system suggests that
proviral integration in or close to heterochromatin regions
promotes latency (Lewinski et al., 2005). Also integration in
the opposite direction to the host gene or intron sites results
in antisense transcripts (Landry et al., 2007). In this context,
acetylation of histones and histone-associated proteins might
play a key role. Usually, acetylation of nuclear proteins directly
influences transcription activity by enabling access of the
transcription machinery to the promoters. On the contrary,
protein-deacetylation apparently restricts transcription factor
(TF) binding, which results in gene silencing. This classical
rule holds also true for HIV, reflected by a series of studies
demonstrating that, besides antigenic stimulation of cytokines,
inhibition of KDACs by chemical compounds is sufficient to
reactivate HIV and as a consequence to unmask and sensitize a
proportion of latently infected cells for killing by ART (Moog
et al., 1996; Van Lint et al., 1996; Witvrouw et al., 1997; El
Kharroubi et al., 1998; Quivy and Van Lint, 2002; Shirakawa et al.,
2013). Further experiments disclosed recruitment of KDACs
to the HIV-5′-LTR by transcriptional repressors such as the
alpha-globin transcription factor CP2 (TFCP2) or transcriptional
repressor protein YY1 (YY1) (Coull et al., 2000). Interestingly,
binding of YY1 to the LTR is directly coupled with the T-cell’s
activation state as T cell receptor (TCR)-triggered activation
causes dissociation of this repressor (Bernhard et al., 2013).
Another mechanism of maintaining latency has been discovered
for the P50 subunit of RELA. While the P50/P65 heterodimer
of RELA is a potent activator of HIV transcription (as
discussed earlier), the P50 homodimer serves as an antagonist
of transcription. Dimeric P50 recruits HDAC1 to the LTR,
promoting chromatin condensation and decreased binding
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of RNAPII (Williams et al., 2006; Chan and Greene, 2011).
The transcriptional repressor recombination binding protein
suppressor of hairless (RBPJ, also known as CBF-1) is able
to redirect HDAC1 to the RELA binding element, promoting
maintenance of latency and a lowered association of RNAPII
to the LTR region (Tyagi and Karn, 2007; Bernhard et al.,
2013). Further (co-)repressors or TFs that recruit HDAC1 and
histone deacetylase 2 (HDAC2) to the LTR and are relevant to
establish and endure latency are e.g., B-cell lymphoma/leukemia
11B (BCL11B), transcription factor AP-4 (TFAP4), Myc proto-
oncogene protein (MYC) or SP1 (Marban et al., 2005, 2007; Imai
and Okamoto, 2006; Jiang et al., 2007; Keedy et al., 2009). More
evidence for the importance of KDACs for HIV latency was
provided by the Margolis laboratory, which demonstrated that (i)
HDACs 1, 2, and 3, but not HDACs 4, 5, 7, and 9 associate with
the 5′-LTR in latency model cell lines, (ii) are expressed in the
nuclei of resting CD4 T-cells, (iii) and their chemical inhibition
by KDAC inhibitors efficiently induces viral outgrowth (Archin
et al., 2009; Keedy et al., 2009). Furthermore, nucleosomes that
are located to the LTR region, are able to inhibit the movement
of RNAPII (Verdin et al., 1993) – though this block can be
overcome by activation of the cell. Here, nuc-1, a nucleosome
positioned immediately downstream of the HIV transcription
site, has been found to undergo deacetylation by interaction with
KDACs in order to maintain the transcriptionally silent state (He
and Margolis, 2002; Conrad and Ott, 2016).
Another factor involved in latency control is CDK9.
Acetylation of CDK9 by KAT2A/ KAT2B reduces the
transcriptional activity of PTEFB, which in turn silences
transcription of the provirus (Sabò et al., 2008). Notably, in
resting and memory CD4 T-cells, PTEFB levels are already
intrinsically low (Rice, 2013), which generally supports their
latent state.
In cells of the myeloid lineage, Okada and colleagues
identified another mechanism for latency regulation, which is
based on phosphorylation instead of lysine-acetylation. Here,
the endogenous inhibitor of RELA, NF-kappa-B inhibitor alpha
(NFKBIA, also known as IκBα), is enhanced by tyrosine-
protein kinase (JAK)/ phosphatidylinositol 4,5-bisphosphate 3-
kinase (PIK3)-based induction of the host-derived factor COMM
domain-containing protein 1 (COMMD1), thereby reinforcing
latency (Taura et al., 2015). As phosphorylation is well known
for its general impact on transcription (Hunter and Karin, 1992)
it is not surprising that additional factors are controlled via
this PTM in the course of HIV latency. As an example, it was
recently shown that a chemical compound, namely the small
molecule activator of protein phosphatase 1 (SMAPP1) induced
both, HIV-1 latency reactivation and replication. Treatment of
cells with SMAPP1 increased phosphorylation of CDK9 and
caused upregulation of PTEFB and PPP1CA-related proteins
(Tyagi et al., 2015). Moreover, the phosphorylation of histone H1
(H1) via PTEFB is known to be important for the regulation of
chromatin binding. Analysis of a phosphorylation-incompetent
H1.1 mutant disrupted TAT transactivation and caused reduction
of H1 mobility (O’Brien et al., 2010). Low levels of PTEFB
promote the non-mobile condition of H1. Another latency-
promoting factor regulated by phosphorylation is the signal
transducer and activator of transcription 5 (STAT5). Compound
screens revealed that inhibition of a negative feedback loop,
that usually sumoylates phosphorylated STAT5, sustained its
phosphorylated state. This increases activity and occupancy of
the HIV-1 LTR and subsequently causes latency reversal (Bosque
et al., 2017).
Other PTMs directly related to HIV latency are protein-
methylation and -ubiquitination, which will be discussed only
briefly in this review. Trimethylated histones are a well-known
modification in repressive heterochromatin (Stewart et al., 2005;
Saksouk et al., 2015) and, as expected, have been observed for
5′-LTR associated nucleosomes during latency (du Chéné et al.,
2007; Marban et al., 2007; Pearson et al., 2008). Consequently,
several accompanied histone methyltransferases (HMTs) have
been identified to reside at latent proviral 5′-LTRs. Examples
are the histone-lysine N-methyltransferases SUV39H (SUV39H1),
EHMT2 (EHMT2) or the EZH2 (EZH2) (du Chéné et al., 2007;
Marban et al., 2007; Imai et al., 2010; Friedman et al., 2011;
Mbonye and Karn, 2014). Especially EZH2 has been proposed as
one of the major regulators of latency, as it not only methylates
H3 on lysine K27, but also resembles the catalytic subunit of
polycomb repressive complex 2 (PRC2). This complex (together
with PRC1) localizes at specific sites called polycomb repressive
elements and organizes the chromatin into a repressive structure
that is unresponsive to chromatin remodeling factors and basal-
and gene-specific transcription factors (Otte and Kwaks, 2003).
Moreover, PRC2 has been shown to recruit several repressive
chromatin modifiers like DNA (cytosine-5)-methyltransferase 1
(DNMT1) as well as HDAC1 and 2 (Van Der Vlag and Otte, 1999;
Tonini et al., 2004; Montgomery et al., 2005).
An example for the involvement of ubiquitination in latency,
is the E3 ubiquitin-protein ligase SIAH1 (SIAH1), which has
been identified by Zhou and colleagues (Liu et al., 2012)
as the E3 ubiquitin ligase for elongation factor for RNA
polymerase II 2 (ELL2). ELL2 forms together with ELL1,
TAT, CCNT1, CDK9, AF4/FMR2 Family Members 1 and 4
(AFF1/4) and other members the super elongation complex
(SEC), which is required for active transcription. SIAH1 causes
polyubiquitination and subsequent proteasomal degradation
of ELL2 in actively replicating cells and absence of ELL2
strongly inhibits TAT-related gene expression (He et al., 2010).
Interestingly, both, activated TAT and the SEC scaffold protein
AFF4, prevent degradation of ELL2 leading to a more profound
transcription of viral genes (Liu et al., 2012). Taken together,
the interplay of several factors – mainly located close to or
recruited to the 5′-LTR – is able to promote or prevent latency
(Figures 4A,B). Thereby, not only the integration site, but
also local protein concentrations together with different PTMs
control a positive or negative transcriptional environment for the
provirus.
Translation, Assembly, Budding and Final
Maturation
At present, insights into the involvement of PTMs during
the last steps of the HIV replication cycle are limited.
Viruses completely rely on the host protein synthesis
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machinery – consisting of ribosomes, tRNAs, amino acids
and associated factors for translation-initiation, -elongation
and -termination. Moreover, innate antiviral restriction factors
as well as stress responses have to be circumvented and at
the same time the cellular tRNA pool has to be used in an
efficient way. Additionally, intracellular transport networks and
cofactors have to be exploited for virion assembly and particle
maturation, respectively. All these requirements necessitate an
interplay of the virus with specific cellular pathways, which
are undoubtedly regulated via PTMs (Figure 5). One of these
counteractions is based on the production of IFNs upon host’s
detection of viral encounters. Expression of IFN in combination
with the presence of viral RNAs leads to induction and
activation of EIF2AK2, which phosphorylates several substrates
including eukaryotic translation initiation factor 2 subunit 1
(EIF2S1). This modification shuts down general synthesis of
proteins in order to prevent viral protein production. Here,
HIV-1 TAT compromises the function of IFN-inducible double-
stranded RNA-dependent protein kinase activator A (PRKRA)
to block EIF2AK2 activation and thus, the shut-down of
protein translation (Clerzius et al., 2013; Burugu et al., 2014;
Chukwurah et al., 2017). At the same time, the viral factor
VPR takes over the host CUL4/DDB1/E3 ubiquitin-protein
ligase RBX1 (RBX1) complex, finally leading to activation of
the Serine/threonine-protein kinases ATR (ATR) and Chk1
(CHEK1) for prevention of cell cycle progression into mitosis
and induction of G2/M arrest in HIV infected cells. Furthermore,
VPR activates the host crossover junction endonucleases MUS81
(MUS81) and EME1 (EME1) via polyubiquitination of MUS81,
which blocks interferon stimulated gene (ISG) expression
(Roshal et al., 2003; Laguette et al., 2014; Zhou et al., 2016).
Several lines of evidence also demonstrated a selective
suppression of mRNA translation in lymphocytes accompanied
with VPR-induced cell cycle arrest. The molecular basis
for this effect seems to be related to reduced levels of the
phosphorylated eukaryotic translation initiation factor 4E
(EIF4E) and EIF4E-binding protein 1 (EIF4EBP1) (Sharma
et al., 2012) (Figure 5). Interestingly, due to composition
of the viral mRNA-ribonucleoprotein complexes, harboring
components of the nuclear cap binding complex (CBC), viral
protein synthesis is sustained in comparison to suppressed
host protein translation (Sharma et al., 2012). After translation
of viral proteins, exploitation of the host protein sorting
and trafficking pathways becomes crucial for assembly of
virions. For this, as in the early steps of infection, the actin-
tubulin-network has to be altered (Jolly et al., 2007), which
is likely accompanied with acetylation, phosphorylation, and
ubiquitination events. Indeed, ubiquitination is involved in the
sorting of HIV proteins. For example, the human trans-Golgi
network (TGN) associated E3 ubiquitin-protein ligase SH3RF1
(SH3RF1) was identified as an important sorting factor for GAG’s
localization to the plasma membrane (Alroy et al., 2005). Further
experiments identified programmed cell death 6-interacting
protein (PDCD6IP, also known as AIP1), a member of the
endosomal sorting complex required for transport (ESCRT)
machinery, as substrate of SH3RF1, which is obligatory for
HIV-1 release (Votteler et al., 2009). Another E3 ubiquitin ligase
that is involved in the regulation of GAG transport to the cell
surface is the susceptibility gene 101 protein TSG101 (TSG101)
associated E3 ubiquitin-protein ligase LRSAM1 (LRSAM1)
FIGURE 5 | Viral protein translation and virus assembly. The interaction network visualizes processes, which are accompanied with the late steps of HIV infection
and the formation of new virions. Figure legend as in Figure 2A. More detailed information can be found in the text.
Frontiers in Microbiology | www.frontiersin.org 13 September 2018 | Volume 9 | Article 2131
fmicb-09-02131 September 10, 2018 Time: 16:36 # 14
Chen et al. PTM-Based HIV-Host Interactions
(Amit et al., 2004). TSG101 belongs to the ESCRT complex
and is engaged by GAG for efficient HIV-1 budding (Figure 5).
LRSAM1-mediated ubiquitination of TSG101 inactivates its
sorting function. Presumably, by the coordinated action of
a DUB, TSG101 gets recycled and a second round of cargo-
loading is enabled (Amit et al., 2004). Similarly, GAG interacts
with the E3 ubiquitin-protein ligase NEDD4-like (NEDD4L),
which stimulates in liaison with TSG101 the release of HIV
virions (Chung et al., 2008). Due to technical limitations,
the identification of specific DUBs relevant for HIV remains
unknown. However, recently, Setz et al. could show that ubiquitin
carboxyl-terminal hydrolases 7 (USP7)- and 47 (USP47)-specific
inhibitors P22077 and PR-619 are able to impair GAG processing
and affect infectivity of released HIV virions, underscoring
the importance of DUBs in HIV biology (Setz et al., 2017).
Expectedly, cellular countermeasures have evolved utilizing the
ubiquitination system to inhibit virus assembly. One example
is the E3 ubiquitin-protein ligase MARCH8 (MARCH8), which
downregulates several host transmembrane proteins including
HLA class II histocompatibility antigen (HLA-II, also known as
MHC class II) or T-lymphocyte activation antigen CD86 (CD86).
Experiments identified MARCH8 as a new restriction factor
that blocks the incorporation of HIV-1 envelope glycoprotein
into virus particles by downregulating it from the cell surface
(Tada et al., 2015). Other PTMs are also involved in cellular
localization of GAG molecules and correct assembly of HIV
particles. Using a proteomic approach, phosphorylation of
GAG by the PRKC was detected. This phosphorylation event
is necessary for the interaction between GAG and VPR and
results in the incorporation of VPR into the virions (Kudoh et al.,
2014). A second kinase that regulates viral assembly and release
via GAG phosphorylation is MAPK1 (Hemonnot et al., 2004).
MAPK1 phosphorylates the MA/P17 of HIV and gets itself
incorporated into newly formed virions (Jacqué et al., 1998).
However, the precise mode of action remains to be explored.
Several other serine-threonine kinases are directly incorporated
into the virions as well, such as PRKA (Cartier et al., 2003) and
serine-threonine kinase 38/38 Like (STK38/STK38L), respectively
(Devroe et al., 2005). STK38 and STK38L were found to be
proteolytically processed by the viral protease PR in the virions
as well as within infected producer cells. Truncation at the PR
cleavage site altered subcellular localization of STK38L and
inhibited the enzymatic activity of STK38 and STK38L (Devroe
et al., 2005). In addition, viral integrase IN binds SAP18 and
supports incorporation into progeny viral particles together with
other compounds of the SIN3A/HDAC1 complex (Figure 5).
Fluorescence-based assays revealed significant KDAC activity
of virions and demonstrated a positive effect of HDAC1 for
infectivity (Sorin et al., 2009).
Besides facilitating virion assembly and co-incorporation, viral
proteins are also active in depletion or inactivation of antiviral
factors, which counteract particle infectivity. During particle
generation, the viral protein VIF is found in the cytoplasm
to employ different strategies for antagonizing APOBEC3F/3G
(Figure 5). In the absence of VIF, APOBEC3G or APOBEC3F
become incorporated into budding virions and impede reverse
transcription and integration in a newly infected cell (see also
uncoating & RT) (Harris et al., 2003; Mangeat et al., 2003;
Zhang et al., 2003; Bishop et al., 2004; Liddament et al.,
2004; Yu et al., 2004). VIF inhibits APOBEC3G packaging
by competing with binding to viral RNA or the nucleocapsid
(Kao et al., 2003; Mariani et al., 2003). Furthermore, VIF
recruits the cellular E3 ligase cullin-5 (CUL5), elongin B and
C (ELOB/ELOC), and RBX1 to form a SCF-like complex for
proteasomal degradation of APOBEC3G, a process that is
further controlled by phosphorylation events within the complex
(Conticello et al., 2003; Marin et al., 2003; Stopak et al., 2003; Yu,
2003; Mehle et al., 2004).
Another factor, playing an important role in viral restriction
and being antagonized by a viral factor during assembly is the
bone marrow stromal antigen 2 (BST2, also known as tetherin).
The interferon-induced protein BST2 impedes detachment of
assembling viral particles at the cell surface of the producer cell
(Neil et al., 2008; Van Damme et al., 2008). The viral membrane
phospho-protein VPU [in some cases also the negative regulatory
factor (NEF) or ENV (HIV-2)] hijacks the cellular BST2
trafficking and turnover machinery, thereby facilitating viral
release (Neil et al., 2008; Van Damme et al., 2008; Sauter et al.,
2009; Hauser et al., 2010; Kluge et al., 2014; Arias et al., 2016)
(Figure 5). Under steady-state conditions, BST2 cycles between
the plasma membrane, the trans-Golgi Network and endosomes,
with a fraction getting sorted to lysosomal degradation via the
ESCRT pathway. Studies demonstrated that, mediated by CSK2
phosphorylation (Schubert et al., 1992, 1994), VPU complexes
with BST2 and binds to the clathrin-associated adaptor protein
complexes 1 (AP1) or 2 (AP2) (Kueck et al., 2015), which restrains
BST2 from its mode of action. Moreover, phosphorylated VPU
recruits the SCF-F-box/WD repeat-containing protein 1A (BTRC)
E3 ligase complex, which leads to ubiquitination of BST2
and thus an enhanced recruitment of BST2 by the ESCRT
machinery and subsequent degradation (Douglas et al., 2009;
Mangeat et al., 2009; Mitchell et al., 2009; Janvier et al., 2011;
Tokarev et al., 2011; Agromayor et al., 2012). Another function
of VPU is to block RELA signaling in the late state of the
HIV replication cycle, as RELA also regulates the antimicrobial
immune response, including the expression of ISGs that protect
against viral pathogens (Pfeffer, 2011). It has been shown that
while NEF increases RELA activity (as described earlier), VPU
stabilizes NFKBIA by preventing its polyubiquitination and
degradation via sequestration of the adaptor protein BTRC (Kroll
et al., 1999; Akari et al., 2001; Bour et al., 2001; Sauter et al.,
2015). Thereby, nuclear translocation of P65 and subsequent
RELA activation is impeded (Sauter et al., 2015). To note,
it has been reported that BST2 displays an additional innate
sensing function, which activates RELA-driven antiviral immune
responses and thus being also affected by VPU’s anti-BST2
activity (Cocka and Bates, 2012; Galão et al., 2012; Tokarev et al.,
2013).
A further example is the exploitation of the host cell
membrane-proteome to avoid detection by the immune system.
As production of viral proteins is accompanied by defective
ribosomal products (DRiPs) (Yewdell et al., 2001), which can
end up as antigenic peptides presented on HLA class I (HLA-I)
molecules to report cell infection, viruses have adapted specific
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mechanisms to circumvent cytotoxic T-cell recognition. In case
of HIV, NEF interferes with the normal trafficking pathway
of HLA-I and thus reduces recognition and lysis of infected
cells by cytotoxic T cells (Wonderlich et al., 2011) (Figure 5).
Currently, two models are discussed, which might take place
at different times of the replication cycle. In the first model,
NEF binds and activates TGN-specific SRC-family kinases, which
subsequently trigger PIK3-dependent endocytosis of cell surface
HLA-I (Blagoveshchenskaya et al., 2002). In the second model,
NEF directly interacts with the cytoplasmic tail of HLA-I for
shuttling to the lysosomal compartment (Schaefer et al., 2008).
In addition, NEF as well as VPU, target the surface-expressed
CD4 molecules for downregulation (Guy et al., 1987; Willey
et al., 1992). Thereby, NEF induces endocytosis by linking the
cytosolic tail of CD4 to components of the cellular protein
trafficking machinery (Chaudhuri et al., 2007). In contrast,
VPU targets newly synthesized CD4 for ubiquitination in an
Endoplasmic Reticulum associated protein degradation (ERAD)-
related pathway at the ER level, which also involves recruitment
of the SCF-BTRC E3 ligase complex (Willey et al., 1992;
Margottin et al., 1998; Magadán et al., 2010). Downregulation
of surface CD4 lowers the risk of superinfection of the cell and
promotes viral egress as it prevents retention of newly assembled
virions at the cell surface (Ross et al., 1999). All these observations
demonstrate the importance of PTMs within the final steps
of HIV assembly and release (see also Figure 5). However,
a more comprehensive picture of the late molecular steps of
the replication cycle requires a further focus on PTM-related
processes.
CONCLUSION AND FUTURE OUTLOOK
Given the broad role of PTMs in every step of the HIV replication
cycle and by controlling and fine-tuning almost every cellular
process, it is likely that many additional interactions will be
discovered in future. Recent methodological advances in the field
of mass spectrometry-based proteome-wide screens will allow for
the first time broad-range and unbiased investigations of changes
in the global PTM landscape. Moreover, new and sensitive
methods for label-free quantitative interaction-proteomics in
primary cells have become available, which permit detection of
weak interactors with spatial and temporal resolution. These
developments in combination with thorough follow-up studies
will hopefully help to identify vulnerable nodes of virus-
host interaction, facilitating so far unappreciated therapeutic
approaches for the treatment of HIV infected individuals
or protection of those at risk of infection. Moreover, many
discoveries might be transferable to other scientific fields enabling
the generation of new molecular tools for basic research as well as
for the treatment of other epidemics. We hope that this review
helps to arouse the interest in PTM-related virological research
and apologize to all investigators in the field for the arbitrary
selection of processes, covering only a small part of important
scientific findings.
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